Skip to main content
iDNA Genomics Public Ltd logo

iDNA Genomics Public Ltd — Investor Relations & Filings

Ticker · IDNA ISIN · CY0109800710 LEI · 2549006HMJWPY9CIB812 CSE Human health and social work activities
Open in API
Filings indexed 80 across all filing types
Latest filing 2025-09-09 Declaration of Voting R…
Country CY Cyprus
Listing CSE IDNA

About iDNA Genomics Public Ltd

https://idnagenomics.com/en/

iDNA Genomics Public Ltd is a biotechnology company specializing in genetic analysis and precision medicine. It develops and provides DNA tests focused on three main areas: pharmacogenetics, which analyzes how genes affect a person's response to drugs; preventive medicine, which screens for genetic predispositions to diseases; and wellness genomics, which informs personalized nutrition and exercise plans. The company's product portfolio includes tests for cardiovascular health and responses to central nervous system medications. Genetic analysis is performed in its certified laboratories, supported by a proprietary bioinformatics platform and an artificial intelligence database that is continuously updated with recent scientific data to ensure accuracy. iDNA Genomics also provides the myEMR online platform for individuals and healthcare professionals to register test kits and manage genetic results.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from iDNA Genomics Public Ltd regarding the results of its Annual General Meeting (AGM). It explicitly lists the outcomes of the meeting, including the approval of financial statements, the re-election of a board member, and the re-appointment of auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-09-09 Greek (modern)
Proxy Solicitation & Information Statement 2025
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Form' (Πληρεξούσιο Έγγραφο) for an Annual General Meeting (AGM) of IDNA GENOMICS PUBLIC LTD. It provides shareholders with the ability to appoint a proxy and includes specific voting instructions for agenda items such as the re-election of a board member and the reappointment of auditors. This type of document is a standard material sent to shareholders to solicit their votes and provide information for the meeting, which falls under the category of Proxy Solicitation & Information Statement.
2025-08-07 Greek (modern)
Annual Report 2024
Annual Report Classification · 100% confidence The document is a comprehensive financial report titled 'ΕΚΘΕΣΗ ΚΑΙ ΕΝΟΠΟΙΗΜΕΝΕΣ ΟΙΚΟΝΟΜΙΚΕΣ ΚΑΤΑΣΤΑΣΕΙΣ 31 Δεκεμβρίου 2024' (Report and Consolidated Financial Statements for the year ended December 31, 2024). It includes a Board of Directors report, an independent auditor's report, consolidated financial statements (balance sheet, income statement, cash flows), and detailed notes. Since it covers a full fiscal year and contains audited financial statements, it is classified as an Annual Report (10-K equivalent for non-US entities). FY 2024
2025-08-05 Greek (modern)
Report Publication Announcement 2025
Report Publication Announcement Classification · 99% confidence The document is very short (769 characters) and explicitly states that the audited annual financial statements for the year ended December 31, 2024, are expected to be approved and *published* (δημοσιοποιηθούν) on the Cyprus Stock Exchange (ΧΑΚ) in early August 2025. It is an announcement about the future publication of the annual results, not the results themselves. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2025-07-17 Greek (modern)
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them' and references Article 19 of the EU Market Abuse Regulation. It details a 'SALE' transaction involving 'ORDINARY SHARES' by an entity controlled by a Director. This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing.
2025-03-27 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is explicitly titled 'MANAGERS' TRANSACTIONS' and 'Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them'. It details a 'SALE' transaction involving 'ORDINARY SHARES' by an entity controlled by a Director of the issuer (IDNA GENOMICS PUBLIC LTD) on a specific date (21/3/2025). This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Matching this content to the provided definitions: - Definition 9: Director's Dealing (Code: DIRS) - 'Report of personal share transactions by company directors and executives (insider trades)'. This is a perfect match.
2025-03-24 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.